Published in Theranostics on January 14, 2014
Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol (2015) 1.49
Carbamoyl phosphate synthetase-1 is a rapid turnover biomarker in mouse and human acute liver injury. Am J Physiol Gastrointest Liver Physiol (2014) 0.85
SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration. J Biol Chem (2015) 0.78
A new method to assay protease based on amyloid misfolding: application to prostate cancer diagnosis using a panel of proteases biomarkers. Theranostics (2014) 0.76
Protective effect of Curcuma longa L. extract on CCl4-induced acute hepatic stress. BMC Res Notes (2017) 0.75
Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity? Front Physiol (2015) 0.75
The Importance of Standardization on Analyzing Circulating RNA. Mol Diagn Ther (2016) 0.75
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics (2004) 19.05
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol (2000) 15.79
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature (2005) 10.10
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med (2006) 9.53
Systems biology and new technologies enable predictive and preventative medicine. Science (2004) 7.59
Computational prediction of proteotypic peptides for quantitative proteomics. Nat Biotechnol (2006) 7.56
Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci U S A (2009) 6.91
Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem (1998) 5.99
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology (2003) 4.69
Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry (1995) 4.10
The current state of serum biomarkers of hepatotoxicity. Toxicology (2007) 3.96
Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal Chem (2003) 3.33
Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology (2008) 2.91
Ceruloplasmin metabolism and function. Annu Rev Nutr (2002) 2.52
Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology (2004) 2.26
Role of S-adenosyl-L-methionine in liver health and injury. Hepatology (2007) 2.21
Acetaminophen hepatotoxicity. Clin Liver Dis (2007) 2.11
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol (1995) 2.05
Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl (2004) 1.96
HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology (2011) 1.86
Mildly elevated liver transaminase levels in the asymptomatic patient. Am Fam Physician (2005) 1.85
Special considerations in interpreting liver function tests. Am Fam Physician (1999) 1.80
Serum alanine aminotransferase in skeletal muscle diseases. Hepatology (2005) 1.54
Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A (2007) 1.48
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther (2000) 1.44
Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci (2002) 1.40
Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology (2008) 1.20
Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States. Gastroenterology (2003) 1.19
Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol (2004) 1.18
Betaine-homocysteine methyltransferase: organ distribution in man, pig and rat and subcellular distribution in the rat. Clin Sci (Lond) (1991) 1.11
Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatology (2009) 1.08
Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care (2007) 1.06
Therapy of hepatitis C: patients with normal aminotransferase levels. Hepatology (1997) 1.04
Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. Eur J Biochem (1997) 1.00
A toxicologist's guide to biomarkers of hepatic response. Hum Exp Toxicol (2002) 1.00
Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice. J Neurochem (2010) 0.99
Plasminogen: a brief introduction into its biochemistry and function. Haemostasis (1988) 0.99
Quantitative serum proteomics from surface plasmon resonance imaging. Mol Cell Proteomics (2008) 0.96
S-Adenosylmethionine protects against acetaminophen-induced hepatotoxicity in mice. Pharmacology (2004) 0.92
Investigation of the mouse serum proteome. J Proteome Res (2005) 0.92
Comparison of S-adenosyl-L-methionine (SAMe) and N-acetylcysteine (NAC) protective effects on hepatic damage when administered after acetaminophen overdose. Toxicology (2007) 0.91
Production of rat soluble and membrane-bound catechol O-methyltransferase forms from bifunctional mRNAs. Biochem J (1993) 0.87
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity. Toxicol Appl Pharmacol (2010) 0.87
Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis. Hepatology (2008) 0.84
[Nutrition assessment protein]. Rinsho Byori (2004) 0.76